A cutoff value of CD133 + CD326− EV levels distinguishing cancer patients and healthy controls has been identified (82.5 EVs/μl) with a sensitivity and specificity of 0.69 and 0.84, respectively (Supplementary ). This evidence concerns the gene PROM1 and cancer.